Shanghai Kaibao Pharmaceutical's actual controller and concerted actor Kaiyi Trading Co. plans to reduce their shareholding by no more than 1%.
Shanghai Kaibao (300039.SZ) announced that the company recently received a consistent letter from the controlling shareholder and actual controller...
Shanghai Kaibao Pharmaceutical (300039.SZ) announced that the company recently received a "Notice of Share Reduction Plan" from its controlling shareholder and actual controller, Ke Yi Shangmao, who is also the consistent actor. Ke Yi Shangmao plans to reduce its shareholding in the company by a total of no more than 10.46 million shares (not exceeding 1% of the company's total share capital) through centralized bidding or block trading within 3 months after 15 trading days from the disclosure of this announcement (from July 23, 2025 to October 22, 2025, except during any window period as stipulated by laws and regulations).
Related Articles
US Stock Market Move | NIKE, Inc. Class B(NKE.US) rises nearly 4% against the trend, with an 18% increase since the performance review.
US Stock Market Move | It is expected to complete the debt restructuring by the end of the third quarter of this year with Wolfspeed (WOLF.US) skyrocketing by 114%.
Lakala Payment (300773.SZ): LEGENDHOLDING intends to reduce its shareholding in the company by no more than 3%.
US Stock Market Move | NIKE, Inc. Class B(NKE.US) rises nearly 4% against the trend, with an 18% increase since the performance review.
US Stock Market Move | It is expected to complete the debt restructuring by the end of the third quarter of this year with Wolfspeed (WOLF.US) skyrocketing by 114%.
Lakala Payment (300773.SZ): LEGENDHOLDING intends to reduce its shareholding in the company by no more than 3%.
